OPT
Click for more information
0.00% 34.5¢ opthea limited

Ann: Opthea Completes Enrollment in First Trial of Sozinibercept, page-8

  1. simons77
    624 Posts.
    lightbulb Created with Sketch. 155
    clock Created with Sketch.
    15/02/24
    10:47
    Post #: 72418626
    that mean we wont see fda approval until 2027.... more diluation
    OPT Price at posting: 59.0¢ Sentiment: Sell Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
watchlist Created with Sketch. Add OPT (ASX) to my watchlist
(20min delay)
Last
34.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $376.5M
Open High Low Value Volume
34.5¢ 35.0¢ 34.0¢ $402.5K 1.164M

Buyers (Bids)

No. Vol. Price($)
19 506452 34.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 1059809 5
View Market Depth
Last trade - 16.10pm 25/06/2024 (20 minute delay) ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.